Postdoctoral Fellowships
Marie Skłodowska-Curie Actions (MSCA) aim to support the career development and training of researchers in all scientific disciplines through international and intersectoral mobility.
The fellows carry out their own research project in collaboration with a host institution, which is indicated at the time of their application. Researchers of all ages, nationalities and scientific disciplines can apply.
Postdoctoral Fellowships (MSCA-PF) provide an extremely enriching experience, that enhance the career perspectives for researchers by developing new scientific competences and gaining international and collaborative research experience.
Complutense as a Host Institution
Complutense
The Complutense University of Madrid (UCM) is a public research university located in Madrid, and one of the oldest universities in the world (founded in 1499).
The UCM enrols over 80,000 students, almost 6,000 faculties and more than 3,000 administration and service staff and consistently ranks as one of the top universities in Spain.
Research Groups
There are more than 200 UCM research groups interested in hosting researchers through MSCA Postdoctoral Fellowships.
They are looking for ambitious, creative and scientifically curious researchers who meet the MSCA-PF eligibility criteria.
If you are ready to take the next step in your research career look into our university's host offers.
European Office
The Complutense University of Madrid as host institution, through a dedicated European Research Office, supports MSCA Postdoctoral Fellowship candidates both in the application process and in managing the grant.
We offer, among other specific support services, an in-depth review of the proposal by experienced advisors: internal deadline to send the draft proposal to office is August 31, 2021.
Expressions of Interest
The next section include information about several UCM supervisors that have expressed their interests to host MSCA experienced researchers in their research group. If you are interested in one of them, you should contact the corresponding Scientific Supervisor directly.
The web search application will help you find the offer that best suits your interests. Just enable and use the filters (click on the filter icon). You can search by faculty, research area, and research topic to be proposed / description of the research group (by means of keywords). Visit the links provided in the search results (table below) to display further information.
Some offers the supervisors ask for particular documents. If you are required to submit a project proposal or you do not know exactly what send to present your candidature, you can use our template 'One Page Proposal'.
The SBRG was founded by Prof. María Vallet-Regí in the 1990s at the Faculty of Pharmacy of University Complutense of Madrid. Since then, our group have been devoted to the design, development and evaluation of biomaterials, mainly to those aimed for bone tissue regeneration and treatment of bone-related pathologies such as bone tumors, osteoporosis and bone infections.
Currently SBRG is an international reference in the field of biomaterials, with more than 800 articles, 20 books, 12 patens and more than 33 M € attracted since its foundation, being worldwide known as one of the most important research teams in the field of bioactive glasses and mesoporous materials for drug delivery.
The interested fellow would be integrated in the Mesoporous bioactive glasses unit, which is currently directed by three senior members: Professor Daniel Arcos, Dr. Isabel Izquierdo-Barba and Dr. Blanca González Ortiz, together with a group of three veterinarian researchers responsible for in vivo preclinical studies and a hematologist responsible of the development of humanized matrixes (see project description below)
Finally, the wide network of European collaborators allow us develop biomaterials from their initial design until preclinical in vivo studies
The challenge we want to address is the preparation of humanized matrices for drug screening in the treatment of leukemia. One of the main challenges in the field of hematological neoplasia, and more specifically in leukemia, is the difficulty in choosing an appropriate treatment since there are no in vivo or in vitro models that mimic the environment in which these diseases develop. By preparing macroporous scaffolds made of MBG, humanized matrices can be designed for the pharmacological screening of hematological neoplasia. The ability of mesoporous bioactive glasses to develop an apatite-like phase similar to the mineral component of bone, should serve as a substrate on which to mimic the hematopoietic niche (HN), incorporating endothelial, mesenchymal, osteoblastic and, finally, leukemic cells. The hypothesis we want to demonstrate is that these matrices will be effective tools to carry out drug screening in the treatment of leukemia.
Specifically, the proposal includes the design and preparation of scaffolds capable of simulating trabecular bone and combining them with another spongy biomaterial that simulates bone marrow, thus devising a 3D system with the capacity to host different cell types that make up the HN, such as HUVEC and mesenchymal cells (perivascular niche) as well as osteoblasts (endosteum niche).
Letter of motivation
Tenure-Track Position for Marie Skłodowska-Curie Global Fellowships?
The "Plan de Actuaciones en Profesorado 2020-23 (ES)" of the Complutense University includes among its calls several options for further hiring of researchers with a PhD. All options require an excellent CV and being granted National Accreditation.
Among the requirements for the stabilization of a Researcher to Assistant Professor, it is required that the researcher has spent at least 3 years as a researcher hired by the UCM in a competitive public call.
Global Fellowships are open to researchers currently within or outside Europe who want to move to a Third Country for 1-2 years and then come back to the Complutense University for an additional year. Therefore, researchers who have been awarded a three-year Global Fellowship would be, after the end of the project and with the current regulatory framework, in a position to meet this condition.
In certain situations, it has been possible for a researcher with at least 2 years working at UCM to opt for a position as a junior Associate Professor.
